-
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Average Recommendation of "Buy" by Analysts
ソース: Buzz FX / 03 11 2024 01:41:16 America/New_York
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Average Recommendation of "Buy" by Analysts Written by MarketBeat November 3, 2024 Share Link copied to clipboard. Shares of ARS Pharmaceuticals, Inc. ( NASDAQ:SPRY - Get Free Report ) have been
Read more...